Genmab

Genmab shuffles C-Suite on commercialization, manufacturing as portfolio grows
Fierce Pharma
Mon, 08/19/24 - 11:02 am
Genmab
restructuring
Exelixis drops tissue factor-targeting ADC after deciding it's no match for Tivdak
Fierce Biotech
Wed, 08/7/24 - 11:19 am
Exelixis
antibody-drug conjugate
tissue factor
XB002
Tivdak
Pfizer
Genmab
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
BioSpace
Thu, 06/27/24 - 11:25 am
FDA
AbbVie
Genmab
Epkinly
relapsed or refractory follicular lymphoma
ASCO24 preview: A look at some of the cancer meeting’s hottest abstracts
BioSpace
Fri, 05/31/24 - 11:03 am
ASCO 2024
Merus
JNJ
CAR-T
Legend Biotech
Pfizer
Genmab
Nanobiotix
Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition
BioSpace
Wed, 04/3/24 - 11:38 am
Genmab
M&A
ProfoundBio
antibody-drug conjugate
Genmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly
Fierce Pharma
Thu, 03/28/24 - 04:59 pm
Genmab
Epkinly
AbbVie
hirings
New Jersey
Genmab grows up: Celebrating 25 years, CEO prepares to wield 'pretty good buying power'
Fierce Biotech
Thu, 03/14/24 - 11:35 am
Genmab
Jan van de Winkel
Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson
Fierce Pharma
Wed, 01/24/24 - 10:33 am
JNJ
Darzalex
Genmab
legal
Genmab and Seagen’s TIVDAK trial meets primary endpoint
Clinical Trials Arena
Tue, 09/5/23 - 11:24 am
Genmab
Seagen
Tivdak
clinical trials
cervical cancer
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
AbbVie
Genmab
Roche
follicular lymphoma
bispecific antibodies
epcoritamab
Lunsumio
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
Clinical Trials Arena
Wed, 06/28/23 - 10:27 am
AbbVie
Genmab
Epkinly
clinical trials
relapsed or refractory follicular lymphoma
AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race
Fierce Pharma
Sun, 05/21/23 - 07:46 pm
AbbVie
Genmab
FDA
anti-CD20
epcoritamab
diffuse large B-cell lymphoma
Epkinly
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Benzinga
Tue, 04/25/23 - 10:28 am
Genmab
JNJ
Janssen
Darzalex
Argenx, Genmab pool expertise on antibody discovery, joining forces to expand into new therapeutic areas
Fierce Biotech
Mon, 04/17/23 - 11:19 am
Genmab
Argenx
antibody discovery
drug discovery
cancer
immunology
AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday
Fierce Biotech
Mon, 11/21/22 - 10:12 am
AbbVie
Genmab
FDA
Roche
epcoritamab
bispecific antibodies
relapsed or refractory large B-cell lymphoma
AbbVie & Genmab EHA Data Indicate LBCL Drug Could Fill Unmet Need
BioSpace
Mon, 06/13/22 - 09:51 pm
AbbVie
Genmab
clinical trials
LBCL
epcoritamab
AbbVie preps filings for lymphoma bispecific licensed from Genmab
Pharmaforum
Thu, 04/14/22 - 10:39 am
AbbVie
Genmab
cancer
epcoritamab
large B-cell lymphoma
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight
Fierce Pharma
Fri, 04/8/22 - 10:22 am
JNJ
Genmab
Darzalex
Multiple Myeloma
drug royalties
With $415M on the line, Genmab taps Synaffix for antibody-drug conjugate technologies
Fierce Biotech
Tue, 01/4/22 - 10:41 am
Genmab
Synaffix
antibody-drug conjugate

Pages